Amador, C., Greiner, T. C., Heavican, T. B., Smith, L. M., Galvis, K. T., Lone, W. G., Bouska, A.
, D'amore, F., Bjerregård Pedersen, M., Pileri, S. A., Agostinelli, C., Feldman, A. L., Rosenwald, A., Ott, G., Mottok, A., Savage, K. J., de Leval, L., Gaulard, P., Lim, S. T. ... Lymphoma/Leukemia Molecular Profiling Project (2019).
Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry.
Blood,
134(24), 2159-2170.
https://doi.org/10.1182/blood.2019000779Ludvigsen, M., Kamper, P., Hamilton-Dutoit, S. J., Bendix, K., Møller, M. B.
, d'Amore, F. A. & Honoré, B. (2015).
Relationship of intratumoural protein expression patterns to age and Epstein-Barr virus status in classical Hodgkin lymphoma.
European Journal of Haematology,
95(2), 137-149.
https://doi.org/10.1111/ejh.12463
Hemmingsen, J. K., Enemark, M. H., Pedersen, A. K., Sørensen, E. F., Lauridsen, K. L., Løhde, J. B., d’Amore, F., Hamilton-Dutoit, S. J., Bjerre, M. & Ludvigsen, M. (2025).
Reduced Activity of Soluble Fibroblast Activation Protein (sFAP) Represents a Biomarker of Aggressive Disease in Lymphoid Malignancies.
International Journal of Molecular Sciences ,
26(23), Article 11248.
https://doi.org/10.3390/ijms262311248
Abrahamsson, A., Albertsson-Lindblad, A., Brown, P. N., Baumgartner-Wennerholm, S., Pedersen, L. M.
, D'Amore, F., Nilsson-Ehle, H.
, Jensen, P., Pedersen, M., Geisler, C. H. & Jerkeman, M. (2014).
Real world data on primary treatment for mantle cell lymphoma: a Nordic Lymphoma Group observational study.
Blood,
124(8), 1288-95.
https://doi.org/10.1182/blood-2014-03-559930Madsen, C., Plesner, T. L.
, Bentzen, H. H. N., Jørgensen, J. M., Sillesen, I. B., Himmelstrup, B. M., Josefsson, P., Plesner, T., Bennedsen, T. L.
, Ludvigsen, M. & d'Amore, F. A. (2020).
Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort.
Leukemia & Lymphoma,
61(11), 2584-2594 .
https://doi.org/10.1080/10428194.2020.1779254
Gang, AO., Stroem, C., Pedersen, M.
, D'Amore, F. A., Pedersen, LM.
, Bukh, A., Pedersen, BB., Moeller, MB., Mortensen, L. S., Gadeberg, O., Ingeberg, S., Mourits-Andersen, T.
, Pulczynski, S. & Brown, P. D. N. (2012).
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group. Annals of Oncology,
23(1), 147-153.
https://doi.org/10.1093/annonc/mdr058Gang, AO., Pedersen, M.
, D'Amore, F. A., Pedersen, LM.
, Bukh, A., Pedersen, BB., Moeller, MB., Mourits-Andersen, T.
, Pulczynski, S. & Brown, P. D. N. (2013).
R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. An updated analysis with 5 years median follow-up of the population-based investigation from the Danish Lymphoma Group.
Hematological Oncology (Online),
31(suppl 1), 167-168.
https://doi.org/10.1002/hon.2058Lugtenburg, PJ., Brown, P. D. N., Van der Holt, B.
, D'Amore, F. A., Koene, HR., Berenschot, HW., Fijnheer, R., Loosveld, O., Bohmer, LH., Pruijt, H., Verhoef, G., Hoogendoorn, M., de Kan, R., Van Imhoff, GW., van Hooije, C., Lam, KH., de Keizer, B., de Jong, D., Hoekstra, OS. & Zijlstra, JM. (2016).
Randomized phase III study on the effect of early intensification of Rituximab in combination with 2-weekly CHOP chemotherapy flollowed by Rituximab or no maintenance in patients with diffuse large B-cell lymphoma: Results from a HOVON-Nordic Lymphoma Group Study. Abstract from ASCO Annual Meeting, United States.
O'Connor, O. A., Özcan, M., Jacobsen, E. D., Roncero, J. M., Trotman, J., Demeter, J., Masszi, T., Pereira, J., Ramchandren, R., Beaven, A., Caballero, D., Horwitz, S. M., Lennard, A., Turgut, M., Hamerschlak, N.
, d'Amore, F. A., Foss, F., Kim, W.-S., Leonard, J. P. ... Lumiere Study Investigators (2019).
Randomized ohase III study of alisertib or investigator's choice (selected single agent) in patients with relapsed or refractory peripheral T-Cell lymphoma.
Journal of Clinical Oncology,
37(8), 613-623.
https://doi.org/10.1200/JCO.18.00899Hohloch, K., Lorsbach, M., Windemuth-Kieselbach, C., Gomez-Codina, J., Likesch, W., Jurczak, W., Cacchione, R., Suh, C., Johnsen, AR.
, D'Amore, F. A., Decaudin, D., Zinzani, PL. & Trümper, L. (2011).
Radioimmunotherapy confers long-term survival to lymphoma patients with acceptable toxicity: Registry analysis of 1100 patients by the international Radioimmunotherapy network (RIT-N).
Journal of Nuclear Medicine,
52(9), 1354-1360.
Ludvigsen, M., Campbell, A. J.
, Enemark, M. B., Hybel, T. E., Karjalainen-Lindsberg, M.-L., Beiske, K.
, Bjerre, M., Pedersen, L. M., Holte, H., Leppä, S.
, Jørgensen, J. M. & Honoré, B. (2023).
Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma.
Blood Cancer Journal,
13(1), Article 161.
https://doi.org/10.1038/s41408-023-00931-6
Haraldsdóttir, H., Brøndum, R. F.
, Enemark, M. B. H., Honoré, B., Ludvigsen, M., Aboo, C., Stensballe, A.
, Jørgensen, J. M., Due, H. & Dybkær, K. (2025).
Proteomic Study of Diffuse Large B-Cell Lymphoma Identifying Proteins Associated with R-CHOP Response.
Biomedicines,
13(11), Article 2709.
https://doi.org/10.3390/biomedicines13112709Beck Enemark, M., Wolter, K., Campbell, A. J.
, Andersen, M. I. D., Sørensen, E. F., Hybel, T. E., Madsen, C., Lauridsen, K. L., Plesner, T. L., Hamilton-Dutoit, S. J., Honoré, B. & Ludvigsen, M. (2023).
Proteomics identifies apoptotic markers as predictors of histological transformation in patients with follicular lymphoma.
Blood Advances,
7(24), 7418-7432.
https://doi.org/10.1182/bloodadvances.2023011299
Vase, M. Ø., Ludvigsen, M., Bendix, K., Hamilton Dutoit, S. J., Møller, M. B., Pedersen, C., Pedersen, G., Obel, N.
, Larsen, C. S., D'Amore, F. A. & Honoré, B. (2016).
Proteomic profiling of pretreatment serum from HIV-infected patients identifies candidate markers predictive of lymphoma development.
AIDS,
30(12), 1889-1898.
https://doi.org/10.1097/QAD.0000000000001152
Andersen, M. D., Wolter, K., Enemark, M. B. H., Pedersen, M. A., Gormsen, L. C., Lauridsen, K. L., Starklint, J., Hamilton-Dutoit, S. J., d'Amore, F., Ludvigsen, M., Honoré, B. & Kamper, P. (2025).
Proteomic Profiling of Lymph Nodes Differentiates Classic Hodgkin Lymphoma With and Without Skeletal Involvement.
European Journal of Haematology, Supplement,
114(1), 173-185.
https://doi.org/10.1111/ejh.14326
Hemmingsen, J. K., Enemark, M. B. H., Sørensen, E. F., Dohrmann, C., Lauridsen, K. L., Hamilton-Dutoit, S. J., Kridel, R.
, Honoré, B. & Ludvigsen, M. (2025).
Proteomic Profiling of Limited-Stage Follicular Lymphoma Reveals Differentially Expressed Proteins Linked to Disease Progression Post-Radiation Therapy.
International Journal of Molecular Sciences (Online),
26(19), Article 9306.
https://doi.org/10.3390/ijms26199306
Petersen, M. A., Rosenberg, C. A., Bill, M., Enemark, M. B., Rahbek, O.
, Roug, A. S., Hasle, H., Honoré, B. & Ludvigsen, M. (2022).
Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients.
Cancers,
14(15), Article 3567.
https://doi.org/10.3390/cancers14153567
Hemmingsen, J. K., Enemark, M. H., Sørensen, E. F., Lauridsen, K. L., Hamilton-Dutoit, S. J., Kridel, R.
, Honoré, B. & Ludvigsen, M. (2024).
Proteomic Profiling Identifies Predictive Signatures for Progression Risk in Patients with Advanced-Stage Follicular Lymphoma.
Cancers,
16(19), Article 3278.
https://doi.org/10.3390/cancers16193278
Ludvigsen, M., Bjerregård Pedersen, M., Lystlund Lauridsen, K., Svenstrup Poulsen, T.
, Hamilton-Dutoit, S. J., Besenbacher, S., Bendix, K., Møller, M. B.
, Nørgaard, P., d'Amore, F. & Honoré, B. (2018).
Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified.
Blood Advances,
2(19), 2533-2542.
https://doi.org/10.1182/bloodadvances.2018019893
Andersen, M. D., Wolter, K., Enemark, M. H., Lauridsen, K. L., Hamilton-Dutoit, S. J., Starklint, J., d’Amore, F., Ludvigsen, M., Honoré, B. & Kamper, P. (2025).
Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity.
Leukemia & Lymphoma,
66(4), 656-667.
https://doi.org/10.1080/10428194.2024.2434170
Holst, J. M., Enemark, M. B., Pedersen, M. B., Lauridsen, K. L., Hybel, T. E., Clausen, M. R., Frederiksen, H., Møller, M. B., Nørgaard, P., Plesner, T. L.
, Hamilton-Dutoit, S. J., D’amore, F., Honoré, B. & Ludvigsen, M. (2021).
Proteomic profiling differentiates lymphoma patients with and without concurrent myeloproliferative neoplasia.
Cancers,
13(21), Article 5526.
https://doi.org/10.3390/cancers13215526
Ludvigsen, M., Thorlacius-Ussing, L., Vorum, H.
, Stender, M. T., Thorlacius-Ussing, O.
& Honoré, B. (2021).
Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers.
Current Issues in Molecular Biology,
43(2), 1043-1056.
https://doi.org/10.3390/cimb43020074
Ludvigsen, M., Thorlacius-Ussing, L., Vorum, H., Moyer, M. P.
, Stender, M. T., Thorlacius-Ussing, O.
& Honoré, B. (2020).
Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer.
International Journal of Molecular Sciences ,
21(10), Article 3466.
https://doi.org/10.3390/ijms21103466
Ludvigsen, M., Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Moeller, M. B., Noergaard, P.
, D'Amore, F. A. & Honoré, B. (2013).
Proteomic analysis identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified. Hematological Oncology,
31, 174-175.
Ludvigsen, M., Pedersen, M. B., Poulsen, T. S.
, Hamilton-Dutoit, S. J., Besenbacher, S.
, Bendix, K., Møller, M. B.
, D'Amore, F. A. & Honoré, B. (2014).
Proteomic Analysis Identifies Outcome-Predictive Clusters in Patients with Peripheral T-Cell Lymphoma, Not otherwise specified: Proteomic Analysis Identifies Outcome-Predictive Clusters in Patients with Peripheral T-Cell Lymphoma, Not otherwise specified.
Blood,
124(21), Article 124.
Ludvigsen, M., Madsen, C.
, Kamper, P., Hamilton-Dutoit, S. J., Bendix, K., D'Amore, F. A. & Honoré, B. (2013).
Proteomic analysis identifies differential expression patterns in follicular lymphoma patients with or without subsequent histological transformation.
Hematological Oncology,
31, 203.
Enemark, M. H., Hemmingsen, J. K., Andersen, M. D., Hybel, T. E., Bjørn, M. E., Josefsson, P. L., Pedersen, L. M., Juul, M. B.
, Pedersen, R. S., Thorsgaard, M.
, Sillesen, I. B., Plesner, T. L.
, Hamilton-Dutoit, S. J., Jensen, P.
, Madsen, C. & Ludvigsen, M. (2024).
Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort.
Blood Cancer Journal,
14(1), 167. Article 167.
https://doi.org/10.1038/s41408-024-01150-3
Clausen, M. R., Ulrichsen, S. P., Juul, M. B., Poulsen, C. B., Iversen, B., Pedersen, P. T., Madsen, J.
, Pedersen, R. S., Josefsson, P. L., Gørløv, J. S.
, Nørgaard, M. & d'Amore, F. (2020).
Prognostic significance of infectious episodes occurring during first-line therapy for diffuse large B-cell lymphoma - A nationwide cohort study.
Hematological Oncology,
38(3), 318-325.
https://doi.org/10.1002/hon.2734
Chan, F. C., Mottok, A., Gerrie, A. S., Power, M., Nijland, M., Diepstra, A., van den Berg, A.
, Kamper, P., d'Amore, F., d'Amore, A. L., Hamilton-Dutoit, S., Savage, K. J., Shah, S. P., Connors, J. M., Gascoyne, R. D., Scott, D. W. & Steidl, C. (2017).
Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma.
Journal of Clinical Oncology,
35(32), 3722-3733.
https://doi.org/10.1200/JCO.2017.72.7925Vajavaara, H., Ekeblad, F., Holte, H.
, Jorgensen, J., Leivonen, S.-K., Berglund, M.
, Kamper, P., Moller, H. J., D'Amore, F., Molin, D., Enblad, G.
, Ludvigsen, M., Glimelius, I. & Leppa, S. (2021).
Prognostic impact of soluble CD163 in patients with diffuse large Bcell lymphoma.
Haematologica,
106(9), 2502-2506.
https://doi.org/10.3324/haematol.2020.278182Clausen, M. R., Maurer, M. J.
, Ulrichsen, S. P., Larsen, T. S., Himmelstrup, B., Rønnov-Jessen, D., Link, B. K., Feldman, A. L., Slager, S. L., Nowakowski, G. S., Thompson, C. A., Pedersen, P. T., Madsen, J.
, Pedersen, R. S., Gørløv, J. S., Cerhan, J. R.
, Nørgaard, M. & D’amore, F. (2019).
Pretreatment hemoglobin adds prognostic information to the nccn-ipi in patients with diffuse large b-cell lymphoma treated with anthracycline-containing chemotherapy.
Clinical Epidemiology,
11, 987-996.
https://doi.org/10.2147/CLEP.S219595
D'Amore, F. A., Jørgensen, J. M., Sillesen, I. B., Segel, E., Bentzen, H. H. N., Thorsgaard, M., Pulcynski, E., Pedersen, B., Gillstrom, D.
, Clausen, M. R., Kamper, P., Silkjær, T., Gormsen, L. C., Leppä, S.
& Toldbod, H. (2014).
Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone, etoposide and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-hodgkin lymphomas.
Blood,
124(21).
Vase, M. Ø., Ludvigsen, M., Bendix, K.
, Dutoit, S. H., Hjortebjerg, R., Petruskevicius, I., Møller, M. B., Pedersen, G.
, Denton, P. W., Honoré, B., Rabinovich, G. A.
, Larsen, C. S. & d'Amore, F. (2017).
Predictive value of galectin-1 in the development and progression of HIV-associated lymphoma.
AIDS,
31(16), 2311-2313.
https://doi.org/10.1097/QAD.0000000000001622
Strandhave, C., Jespersen, B., Jørgensen, KA., Schou, R.
, Søndergaard, E., Bendix, K., Mortensen, LS.
& D'Amore, F. A. (2011).
Posttransplant lymphoproliferative disorders (PTLD) after renal transplantation: Focus on HLA Antigens.
Blood,
116(21), 5074.
Maksten, E. F.
, Vase, M. Ø., Kampmann, J.
, d'Amore, F., Møller, M. B.
, Strandhave, C., Bendix, K., Bistrup, C., Thiesson, H. C.
, Søndergaard, E., Hamilton-Dutoit, S. & Jespersen, B. (2016).
Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study.
Transplant International,
29(4), 483-493.
https://doi.org/10.1111/tri.12744Hutchings, M., Loft, A., Hansen, M., Pedersen, L. M., Berthelsen, A. K.
, Keiding, S., d'Amore, F. A., Boesen, A. M., Mikkelsen, L. R. & Specht, L. (2006).
Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
Haematologica,
91, 482-9.
Barrenetxea Lekue, C., Grasso Cicala, S., Leppä, S., Stauffer Larsen, T., Herráez Rodríguez, S., Alonso Caballero, C.
, Jørgensen, J. M., Toldbod, H., Leal Martínez, I.
& D’Amore, F. (2019).
Pixantrone beyond monotherapy: a review.
Annals of Hematology,
98(9), 2025-2033.
https://doi.org/10.1007/s00277-019-03749-0d'Amore, F., Radford, J., Relander, T., Jerkeman, M., Tilly, H., Osterborg, A., Morschhauser, F., Gramatzki, M., Dreyling, M., Bang, B. & Hagberg, H. (2010).
Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma.
British Journal of Haematology, Supplement,
150(5), 565-73.
https://doi.org/10.1111/j.1365-2141.2010.08298.x
Morschhauser, F., Radford, J., Van Hoof, A., Vitolo, U., Soubeyran, P., Tilly, H., Huijgens, P. C., Kolstad, A.
, d'Amore, F., Gonzalez Diaz, M., Petrini, M., Sebban, C., Zinzani, P. L., van Oers, M. H. J., van Putten, W., Bischof-Delaloye, A., Rohatiner, A., Salles, G., Kuhlmann, J. & Hagenbeek, A. (2008).
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
Journal of Clinical Oncology,
26(32), 5156-64.
https://doi.org/10.1200/JCO.2008.17.2015Barrington, S. F., Kirkwood, A. A., Franceschetto, A., Fulham, M. J., Roberts, T. H., Almquist, H., Brun, E.
, Hjorthaug, K., Viney, Z. N., Pike, L. C., Federico, M., Luminari, S., Radford, J., Trotman, J., Fosså, A., Berkahn, L., Molin, D.
, D'Amore, F., Sinclair, D. A. ... Johnson, P. W. (2016).
PET-CT for staging & early response: results from 'Response Adapted Therapy in Advanced Hodgkin Lymphoma' (RATHL) (CRUK/07/033).
Blood,
127(12), 1531-1538.
https://doi.org/10.1182/blood-2015-11-679407Meier, M., Knudsen, A. R., Andersen, K. J., Ludvigsen, M., Lykke Eriksen, P., Pedersen, A. K. N., Honoré, B. & Mortensen, F. V. (2019).
Perturbations of urea cycle enzymes during post-hepatectomy rat liver failure.
American Journal of Physiology: Gastrointestinal and Liver Physiology,
317(4), G429-G440.
https://doi.org/10.1152/ajpgi.00293.2018